References
- ToniCPerugiGFrareFMataBAkiskalHSSpontaneous treatment discontinuation in panic disorder patients treated with antidepressantsActa Psychiatr Scand2004110213013715233713
- JohnsonDADepression: treatment compliance in general practiceActa Psychiatr Scand Suppl19812904474536939323
- PerlisRHMischoulonDSmollerJWSerotonin transporter polymorphisms and adverse effects with fluoxetine treatmentBiol Psychiatry200354987988314573314
- PoppJLeuchtSHeresSSteimerWSerotonin transporter polymorphisms and side effects in antidepressant therapy – a pilot studyPharmacogenomics20067215916616515395
- MurphyGMHollanderSBRodriguesHEKremerCSchatzbergAFEffects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depressionArch Gen Psychiatry200461111163116915520364
- HeilsATeufelAPetriSAllelic variation of human serotonin transporter gene expressionJ Neurochem1996666262126248632190
- StahlSMEssential Psychopharmacology: Neuroscientific Basis and Practical Applications2nd edNew YorkCambridge University Press2000
- LouieAKLewisTBLannonRAUse of low-dose fluoxetine in major depression and panic disorderJ Clin Psychiatry199354114354388270588
- IshiguroSWatanabeTUedaMDeterminants of pharmacodynamic trajectory of the therapeutic response to paroxetine in Japanese patients with panic disorderEur J Clin Pharmacol201167121213122121688171
- BandelowBAssessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia ScaleInt Clin Psychopharmacol199510273817673659
- Yasui-FurukoriNNakagamiTKanedaAInverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disordersHum Psychopharmacol201126860260822102561
- MontgomerySAAsbergMA new depression scale designed to be sensitive to changeBr J Psychiatry1979134382389444788
- HikidaKInoueYNouchiEOhkuraYDetermination of etizolam in human serum or plasma using automated column-switching high-performance liquid chromatographyJapanese Journal of Clinical Chemistry1990194354359
- LeschKPBengelDHeilsAAssociation of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory regionScience19962745292152715318929413
- GartlehnerGHansenRACareyTSLohrKNGaynesBNRandolphLCDiscontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysisInt Clin Psychopharmacol2005202596915729080
- GoetheJWWoolleySBCardoniAAWoznickiBAPiezDASelective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherenceJ Clin Psychopharmacol200727545145817873676
- FreireRCLopesFLVerasABPersonality traits spectrum in panic disorder and major depressionRev Bras Psiquiatr2007291313417435925
- SenSBurmeisterMGhoshDMeta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traitsAm J Med Genet B Neuropsychiatr Genet2004127B1858915108187
- YamakawaMFukushimaASakumaKYanagisawaYKagawaYSerotonin transporter polymorphisms affect human blood glucose controlBiochem Biophys Res Commun200533441165117116038876
- SawamuraKSuzukiYSomeyaTEffects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetineEur J Clin Pharmacol200460855355715349705
- UedaMHirokaneGMoritaSThe impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patientsProg Neuropsychopharmacol Biol Psychiatry200630348649116423440